دورية أكاديمية
أعرض في EDS

The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature.

التفاصيل البيبلوغرافية
العنوان: The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature.
المؤلفون: Al-Qudimat AR; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar., Altahtamoun SB; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar., Kilic F; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Sciences, QU-Health, College of Health Sciences, Qatar University, Doha, 2713, Qatar.; Department of Chemistry, Jordan University of Science and Technology, P.O.Box 3030, Irbid, 22110, Jordan., Al-Zoubi RM; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Sciences, QU-Health, College of Health Sciences, Qatar University, Doha, 2713, Qatar.; Department of Chemistry, Jordan University of Science and Technology, P.O.Box 3030, Irbid, 22110, Jordan., Al Zoubi MS; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan.
المصدر: Heliyon [Heliyon] 2024 Jun 24; Vol. 10 (13), pp. e32822. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Elsevier Ltd, [2015]-
مستخلص: Chronic kidney disease (CKD) has been correlated with certain pathological conditions such as cardiovascular diseases and other renal-related dysfunctions. Some other reports suggested an association between CKD and the development of certain solid cancers. Therefore, we aimed to generate this narrative review to present the available literature on the risk of solid cancer development in CKD patient populations. We explored the associations between CKD, organ transplantation, and the development of specific solid organ tumors such as kidney, thyroid, lung, breast, bladder, gastric, and prostate cancers. In conclusion, the previous reports showed an increase in the risk of certain solid cancers such as kidney, lung, bladder, and possibly breast cancer in CKD patients and transplant recipients. On the other hand, thyroid, gastric, and prostate cancers showed unclear association with CKD. Despite the suggested impact of smoking and immunosuppression on the development of cancers in CKD patients, more studies are needed to elucidate the mechanism and the risk factors that might be related to the development of cancer in CKD patients.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2024 The Authors.)
References: Am J Transplant. 2013 Mar;13(3):714-20. (PMID: 23331953)
Semin Dial. 2015 Jul-Aug;28(4):404-12. (PMID: 25929593)
Clin Kidney J. 2019 May 24;12(5):663-672. (PMID: 31584562)
Eur Urol. 2019 Jan;75(1):74-84. (PMID: 30243799)
Eur J Cancer. 2013 Jan;49(2):336-44. (PMID: 23062667)
CA Cancer J Clin. 2023 Jan;73(1):17-48. (PMID: 36633525)
Eur Urol. 2015 Mar;67(3):519-30. (PMID: 25449206)
PLoS One. 2018 Nov 20;13(11):e0207756. (PMID: 30458033)
Br J Cancer. 2003 Oct 6;89(7):1221-7. (PMID: 14520450)
JAMA. 2007 Nov 7;298(17):2038-47. (PMID: 17986697)
J Adv Nurs. 2017 Oct;73(10):2450-2461. (PMID: 28329420)
Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66. (PMID: 11602373)
Hemodial Int. 2018 Apr;22 Suppl 1:S22-S35. (PMID: 29694720)
Am J Transplant. 2007 Apr;7(4):941-8. (PMID: 17331115)
Nephron Clin Pract. 2011;118(3):c269-77. (PMID: 21212690)
Transplantation. 2019 Mar;103(3):581-587. (PMID: 30418430)
Am J Kidney Dis. 2003 Jan;41(1):1-12. (PMID: 12500213)
BMJ. 2010 Feb 11;340:c570. (PMID: 20150194)
Pediatr Transplant. 2020 Dec;24(8):e13780. (PMID: 32542914)
Kidney Int. 2004 Jul;66(1):383-9. (PMID: 15200447)
BMC Res Notes. 2014 Jul 02;7:415. (PMID: 24990184)
JAMA. 2011 Jun 22;305(24):2532-9. (PMID: 21693741)
J Am Soc Nephrol. 2009 Jun;20(6):1341-50. (PMID: 19406977)
J Urol. 2006 Apr;175(4):1240-3; discussion 1243-4. (PMID: 16515969)
Am J Transplant. 2004 Jun;4(6):905-13. (PMID: 15147424)
IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-240. (PMID: 7715070)
Eur J Cancer. 2018 Nov;103:356-387. (PMID: 30100160)
Transplant Proc. 2018 Dec;50(10):3434-3439. (PMID: 30577217)
Am J Transplant. 2010 Aug;10(8):1889-96. (PMID: 20659094)
Health Sci Rep. 2022 Dec 15;6(1):e995. (PMID: 36540568)
Med Sci (Basel). 2020 Mar 13;8(1):. (PMID: 32183076)
J Korean Med Sci. 2019 Jul 01;34(25):e176. (PMID: 31243935)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
Nurs Open. 2022 Mar;9(2):1096-1104. (PMID: 34907670)
Ren Fail. 2017 Nov;39(1):104-111. (PMID: 27832731)
Int J Cancer. 2021 Apr 5;:. (PMID: 33818764)
Biomedicines. 2022 Nov 08;10(11):. (PMID: 36359366)
Children (Basel). 2020 Jun 08;7(6):. (PMID: 32521637)
Clin Exp Nephrol. 2019 Nov;23(11):1323-1330. (PMID: 31372795)
Int J Cancer. 2015 Oct 15;137(8):1953-66. (PMID: 25866035)
Am J Kidney Dis. 2015 May;65(5):763-72. (PMID: 25662835)
Eur Urol. 2017 Jan;71(1):96-108. (PMID: 27370177)
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1284-1297. (PMID: 35775227)
Nutrients. 2023 Mar 24;15(7):. (PMID: 37049428)
Tob Control. 2012 Mar;21(2):96-101. (PMID: 22345230)
Int J Cancer. 2018 Feb 15;142(4):747-756. (PMID: 29023769)
Cancer Epidemiol. 2018 Aug;55:17-22. (PMID: 29758490)
Eur Urol. 2022 Nov;82(5):529-542. (PMID: 36100483)
Nephrol Dial Transplant. 2012 Feb;27(2):833-9. (PMID: 21633099)
Kidney Res Clin Pract. 2019 Mar 31;38(1):60-70. (PMID: 30866180)
Transplantation. 2008 Mar 27;85(6):850-4. (PMID: 18360267)
J Am Soc Nephrol. 2005 Dec;16(12):3728-35. (PMID: 16251239)
Int J Cancer. 2021 Jan 1;148(1):67-76. (PMID: 32638386)
Am J Kidney Dis. 2017 Oct;70(4):512-521. (PMID: 28601406)
Transpl Int. 2000;13 Suppl 1:S394-8. (PMID: 11112040)
Int Urol Nephrol. 2002;33(1):121-6. (PMID: 12090317)
Atherosclerosis. 2009 May;204(1):298-303. (PMID: 18848325)
Cancer Med. 2018 Feb;7(2):485-498. (PMID: 29356425)
Am J Transplant. 2012 Nov;12(11):3039-46. (PMID: 22883513)
Atherosclerosis. 2020 Aug;307:11-15. (PMID: 32702535)
Arch Intern Med. 2008 Nov 10;168(20):2268-75. (PMID: 19001205)
Curr Opin Urol. 2018 Jan;28(1):62-79. (PMID: 29059103)
Cancer Epidemiol. 2011 Apr;35(2):105-11. (PMID: 20674538)
Urol Oncol. 2019 Jun;37(6):359-371. (PMID: 30685335)
Int J Cancer. 2015 Jan 15;136(2):487-90. (PMID: 24889903)
PLoS One. 2015 Apr 13;10(4):e0122856. (PMID: 25874862)
Kidney Int. 2011 Dec;80(12):1258-70. (PMID: 21993585)
فهرسة مساهمة: Keywords: CKD; Kidney transplants; Solid cancers; Solid tumors
تواريخ الأحداث: Date Created: 20240722 Latest Revision: 20240723
رمز التحديث: 20240723
مُعرف محوري في PubMed: PMC11259794
DOI: 10.1016/j.heliyon.2024.e32822
PMID: 39035535
قاعدة البيانات: MEDLINE
الوصف
تدمد:2405-8440
DOI:10.1016/j.heliyon.2024.e32822